PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 15220107

[Vascular graft prosthesis].

N Chakfé·F Dieval·F Thaveau·S Rinckenbach·O Hassani·G Camelot·B Durand·J-G Kretz·Groupe européen de recherche sur les prothèses appliquées à la chirurgie vasculaire
View original source ↗Export metadata ↓

Abstract

Performed since the 1950s, vascular grafting has opened modern era of vascular surgery. Autologous venous grafts are of first choice for revascularisation of small arteries. Synthetic grafts are mainly modelled using microporous polytetrafluoroethylene or terephtalate polyethylene. These prosthesis are mainly used for revascularization of medium and large size arteries.

Explore related subjects

Blood Vessel ProsthesisBlood Vessel Prosthesis ImplantationGraft Occlusion, VascularHumansPatient SelectionPolyethylene TerephthalatesPolytetrafluoroethyleneProsthesis DesignTransplantation, AutologousTransplantation, HeterologousTransplantation, HomologousVascular PatencyJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

N Chakfé, F Dieval, F Thaveau, S Rinckenbach, O Hassani, G Camelot, B Durand, J-G Kretz, Groupe européen de recherche sur les prothèses appliquées à la chirurgie vasculaire. 2004. [Vascular graft prosthesis].. https://doi.org/10.1016/j.anchir.2004.05.002

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Leiomyosarcoma of the superior mesenteric vein: a diagnostic and therapeutic challenge.

We report here a case of a very rare entity, a leiomyosarcoma of the mesentericoportal trunk, which was initially misdiagnosed as an unresectable pancreatic cancer invading the mesenteric vein, and which was finally treated by pancreatectomy with mesentericoportal reconstruction. The pitfalls of diagnosis and modalities of resection are discussed.

Blood Vessel Prosthesis↗
PubMed2006

The evidence for cerebral protection: an analysis and summary of the literature.

It has been considered likely that the majority of cerebral ischaemic episodes following carotid artery stenting are due to cerebral embolisation. It is intuitive therefore, to attempt to prevent these presumptive emboli, whether they are comprised of air or formed elements, from reaching the brain. Various pharmacological and mechanical solutions are being used. The available literature is hampered by comparisons against historical controls of unprotected CAS with many confounding variables that may influence outcome. There is no clinical Level-I evidence to support the use of protection devices but Level-III and Level-IV evidence suggest benefit.

Blood Vessel Prosthesis↗